NHS Dudley Health Economy Medicines Formulary
Home > 5 Infections > 5.3 Antiviral drugs > 5.3.3 Viral hepatitis > 5.3.3.1 Chronic hepatitis B > Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a - NICE TAG TA96

Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alpha-2a - NICE TAG TA96

This guidance was partially updated by NICE clinical guideline 165 in June 2013. See About this guidance for more information.

This guidance does not apply to people with chronic hepatitis B known to be co-infected with hepatitis C, hepatitis D or HIV.

1.1 Peginterferon alfa-2a is recommended as an option for the initial treatment of adults with chronic hepatitis B (HBeAg-positive or HBeAg-negative), within its licensed indications.

1.2 This recommendation has been replaced by recommendation 1.5.13 in NICE clinical guideline 165.

1.3 This recommendation has been replaced by recommendation 1.5.14 in NICE clinical guideline 165.

1.4 This recommendation has been replaced by recommendation 1.5.15 in NICE clinical guideline 165.

http://www.nice.org.uk/guidance/TA96

Site by Devopa
© Copyright 2019 NHS. All rights reserved.